What is the recommended metronidazole (Flagyl) dosage for treating Trichomonas vaginalis infection in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosing for Trichomoniasis

The preferred treatment for trichomoniasis is metronidazole 500 mg orally twice daily for 7 days, which achieves superior cure rates compared to single-dose therapy. 1

Recommended Treatment Regimens

First-Line Therapy

  • Metronidazole 500 mg orally twice daily for 7 days is the preferred regimen, with cure rates of approximately 90-95%. 1
  • This multi-day regimen demonstrates significantly better efficacy than single-dose treatment, with an 8% absolute reduction in treatment failure (11% vs 19% failure rates). 2

Alternative Single-Dose Regimen

  • Metronidazole 2 g orally as a single dose remains an acceptable alternative when adherence to multi-day therapy is a concern. 3, 4
  • While convenient and historically recommended, this regimen has higher failure rates compared to the 7-day course. 2
  • An additional FDA-approved option is Flagyl 375 mg orally twice daily for 7 days, though clinical equivalency data are limited. 3

The choice between regimens should prioritize the 7-day course for optimal cure rates, particularly given that treatment failure leads to persistent infection, ongoing transmission risk, and the need for more intensive retreatment. 2

Critical Management Principles

Partner Treatment (Non-Negotiable)

  • All sexual partners must be treated simultaneously, regardless of symptoms or test results. 1, 4
  • Patients must abstain from sexual intercourse until both partners complete treatment and are asymptomatic. 3, 1
  • Reinfection from untreated partners is the most common cause of apparent treatment failure. 4

Treatment Failure Protocol

If initial therapy fails:

  1. First failure: Re-treat with metronidazole 500 mg twice daily for 7 days. 3, 1
  2. Second failure: Metronidazole 2 g orally once daily for 3-5 days. 3
  3. Persistent failure: Consult infectious disease specialist and obtain susceptibility testing after excluding reinfection. 3, 1

Special Populations

Pregnancy

  • Metronidazole 2 g orally as a single dose is recommended after the first trimester. 3, 1
  • Treatment is important given associations with preterm delivery, premature rupture of membranes, and low birth weight. 1, 4
  • Metronidazole is contraindicated in the first trimester per older guidelines 3, though more recent evidence shows no consistent teratogenic effects. 3

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients. 3, 1
  • Treatment is particularly important as untreated trichomoniasis increases HIV transmission risk. 4

Metronidazole Allergy

  • Desensitization is the recommended approach, as no effective alternatives exist. 3, 4
  • Topical therapies achieve cure rates <50% and should not be used. 3

Common Pitfalls to Avoid

  • Never use metronidazole vaginal gel for trichomoniasis—it achieves <50% efficacy and is only approved for bacterial vaginosis. 3, 4
  • Do not skip partner treatment even if the partner is asymptomatic, as the organism is difficult to isolate in men. 4
  • Always exclude reinfection from untreated partners before assuming true treatment failure. 4
  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment. 3, 1

References

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trichomoniasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.